Evaluation of the Observance and the Tolerance of a Motor Training Program

NCT02844868 | Terminated

• 2 other identifiers: 16081132016-A01249-42
• Study Type: interventional
• Target: 13
• Locations: 1 country
• Sites: 1

Brief Summary

Transcortical direct current stimulation (tDCS) is an emerging technique in the rehabilitation of hemiplegic patients after stroke. This study aims to assess the observance and the tolerance of repeated tDCS stimulation over the primary motor cortex of the lower limb coupled to a motor training program, among hemiplegic patients at the sub-acute stage. This is a prospective, randomized, double-blind, study with two parallel groups of 15 subjects each. The study will analyze first, the patient's observance considered good if 75% of the patients completed the entire protocol duration and the tolerance through a questionnaire. The secondary end point will try to estimate, if possible, the effect size of the walking performance measured with the six-minute walk test and aerobic performance measured with VO2peak of this training program compared to the same program combine with placebo stimulations. These evaluations are performed before, during and after the rehabilitation program.

Conditions

Hemiplegia; Stroke

Keywords

stroke; hemiplegia; transcranial direct current stimulation (tDCS); rehabilitation; lower extremity; gait training

Outcome Measures

Primary Outcomes (1)

• tDCS tolerance

  tolerance questionnaire

  2 months

Secondary Outcomes (1)

• Effect size of TDCS on walking performance

  2 months

Study Arms (2)

Active tDCS

EXPERIMENTAL

During the first 20 min of training program, patient will have active tCDS (2 mA )

Device: Active tDCS

sham tDCS

SHAM COMPARATOR

During the first 20 min of training program, patient will have sham tCDS

Device: Sham tDCS

Interventions

Active tDCS DEVICE

During the first 20 min of training program, patient will have active tCDS : the patient received a 2 mA anodal tDCS over the lower limb ipsilesional motor area. The anodal electrode was positioned on the hotspot previously identified with TMS. The cathode was placed above the contralesional orbit.

Active tDCS

Sham tDCS DEVICE

During the first 20 min of training program, patient will have sham tCDS : the patient received a 2 mA anodal tDCS (only during the first and the last 30 seconds of the stimulation) and then, patient will have sham tDCS. The anodal electrode was positioned on the hotspot previously identified with TMS. The cathode was placed above the contralesional orbit.

sham tDCS

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Having had a first ischemic stroke within 6 months, or have already had a stroke in the same lesion zone.
• No recurrence.
• Responsible of a right or left hemiplegia.
• Able to walk alone with or without technical assistance.
• Over a distance of at least 10 meters.
• Performance on the six-minute walk test less than 400 meters.
• Without neurological history other than stroke.

You may not qualify if:

• Patients who did not have brain MRI after their stroke
• Patients with complete lesion of the primary motor cortex (as identified on MRI).
• Patients with an addiction to alcohol or drugs.
• Patients with psychiatric disease, cognitive impairment disease, uncontrolled epilepsy, neoplastic disease, severe renal or pulmonary failure.
• Patients with cerebellar syndrome associated.
• Patients with clinical involvement of the brainstem (cranial nerve deficit).
• Patients who refused to sign the written consent.
• Patients who have an ongoing pregnancy.
• Patients under justice protection.
• Patients with contraindication to practice aerobic training after stress test.

Sponsors & Collaborators

• Centre Hospitalier Universitaire de Saint Etienne: lead

Study Sites (1)

CHU de SAINT-ETIENNE

Saint-Etienne, 42000, France

Location

MeSH Terms

Conditions

Hemiplegia; Stroke

Condition Hierarchy (Ancestors)

Paralysis; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases

Study Officials

• Pascal GIRAUX, MD

  CHU SAINT-ETIENNE

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 22, 2016
• First Posted: July 26, 2016
• Study Start: February 22, 2018
• Primary Completion: January 31, 2022
• Study Completion: October 3, 2022
• Last Updated: October 19, 2022

Record last verified: 2022-10

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)